Norbert Windhab

Dr. Norbert Windhab is heading the function Strategic Projects at Evonik Industries AG Business Line Health Care since 2008. He spun out the JV from Aventis SA with Nanogen Inc., CA, in the field of DNA-based diagnostics and drug-research as its Managing Director in 2001 and entered Degussa AG, now Evonik Industries in 2005 to initiate clinical programs in nutraceutical product innovation and novel functional drug delivery excipients.

Dr. Windhab is scientific board member at the University of Freiburg BIOSS Government Excellence Center and in the Kuratorium of the Max Planck Institute in Cologne. He is lecturer Pharma Polymers at the University of Jena and invited auditor to Fraunhofer Institutes.